Review paper
Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology
Abstract
Despite standardization of multimodal treatment and approval of several targeted drugs for resectable, non-metastatic cancer (M0 patients), intrinsic and acquired resistance and relapse rates remain high, even in early-stage aggressive tumors. Genome analysis could overcome these unmet needs. Our comprehensive review underlines the controversy on stable or spatiotemporally evolving clones as well as promising yet inconclusive data on...
Paper Details
Title
Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology
Published Date
Nov 1, 2018
Journal
Volume
23
Issue
11
Pages
1848 - 1872
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History